Clincosm LogoSign in Get a demo

cognitive disorders

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

People With Cognitive Disorders

Recruiting
  • Dementia
  • +3 more
    • Verona, VR, Italy
      University Hospital of Verona
    Oct 17, 2023

    Cognitive Disorders Trial (Blood samples, Interviewing the subject and scales, Neurocognitive evaluation)

    Not yet recruiting
    • Cognitive Disorders
    • Blood samples
    • +5 more
    • (no location specified)
    May 25, 2023

    Cognitive Disorders Trial in Russian Federation (MMH-MAP, Placebo)

    Active, not recruiting
    • Cognitive Disorders
    • Arkhangelsk, Russian Federation
    • +21 more
    Jan 20, 2023

    Cognitive Disorders Trial in Dijon (Blood sampling, Cognitive Assessment, Subjective taste tests)

    Completed
    • Cognitive Disorders
    • Blood sampling
    • +3 more
    • Dijon, France
      Chu Dijon Bourgogne
    Dec 14, 2022

    Cognitive and Motor Neurological Disorders in Short and Long

    Completed
    • Cognitive Disorders
    • +2 more
    • Test battery
    • Tours, France
      University hospital
    Sep 5, 2022

    Cognitive Disorders Trial in Leuven (SDI-118, Placebo)

    Completed
    • Cognitive Disorders
    • Leuven, Belgium
      Centre for Clinical Pharmacology, UZ Leuven
    Aug 2, 2022

    Cognitive Disorders, Delirium, Acute Kidney Injury Trial in Rochester (Ketamine, Propofol)

    Completed
    Has Results
    • Cognitive Disorders
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 24, 2022

    Depression, Delirium, Seizures Trial in Saint Louis (Ketamine, Electroconvulsive Therapy)

    Completed
    Has Results
    • Depression
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 25, 2021

    Delirium, Delirium, Dementia, Amnestic, Cognitive Disorders, Delayed Emergence From Anesthesia Trial in Baltimore (Ramelteon,

    Completed
    Has Results
    • Delirium
    • +3 more
    • Baltimore, Maryland
      Johns Hopkins Bayview Medical Center
    Jun 16, 2020

    EGb 761® Effectiveness in Treatment of Patients of Middle Age

    Completed
    • Cognitive Disorders
    • Moscow, Russian Federation
    • +1 more
    Mar 30, 2020

    Delirium, Cognitive Disorders Trial in San Francisco (Processed EEG-guided anesthetic depth)

    Completed
    • Delirium
    • Cognitive Disorders
    • Processed EEG-guided anesthetic depth
    • San Francisco, California
      University of California, San Francisco Medical Center
    Dec 16, 2019

    Everyday Cognition Battery (ECB).

    Unknown status
    • Occupational Therapy
    • +3 more
    • Cognitive Function Evaluation
    • Salamanca, Spain
      Eduardo José Fernández
    Nov 15, 2019

    Mild Cognitive Impairment, Cognitive Disorders Trial in Winston-Salem (5-month aerobic exercise intervention)

    Completed
    • Mild Cognitive Impairment
    • Cognitive Disorders
    • 5-month aerobic exercise intervention
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health
    Sep 25, 2019

    Cognitive Disorders Trial in Nice (Adapted physical activity)

    Unknown status
    • Cognitive Disorders
    • Adapted physical activity
    • Nice, France
      Institut Claude Pompidou - Centre Mémoire de Ressources et de Re
    Mar 5, 2019

    Schizophrenia, Depression, Bipolar Disorder Trial in Baltimore (Physical activity intervention with peer support (PA+PS),

    Completed
    • Schizophrenia
    • +5 more
    • Physical activity intervention with peer support (PA+PS)
    • Physical activity intervention without peer support (PA)
    • Baltimore, Maryland
      Johns Hopkins University
    Dec 4, 2017

    Cognitive Disorders Trial in Overland Park (SUVN-G3031)

    Completed
    • Cognitive Disorders
    • Overland Park, Kansas
      Quintiles
    Sep 21, 2017

    Cognitive Disorders Trial in London (GSK1034702, Placebo)

    Completed
    • Cognitive Disorders
    • London, United Kingdom
      GSK Investigational Site
    Jul 18, 2017

    Cognitive Disorders Trial in London (GSK1043702, Dextromethorphan, Placebo)

    Completed
    • Cognitive Disorders
    • London, United Kingdom
      GSK Investigational Site
    Jul 11, 2017

    Cognitive Disorders Trial in London (GSK1034702)

    Completed
    • Cognitive Disorders
    • London, United Kingdom
    • +1 more
    Jun 26, 2017

    Anesthesia, Surgery, Neurogenic Inflammation Trial (Positron emission tomography (PET) using [11C]PBR28)

    Completed
    • Anesthesia
    • +3 more
    • Positron emission tomography (PET) using [11C]PBR28
    • (no location specified)
    Jan 10, 2017

    Cognitive Disorders Trial in Overland Park (SUVN-G3031, Placebo)

    Completed
    • Cognitive Disorders
    • Overland Park, Kansas
      Quintiles
    Oct 13, 2016

    Multiple Sclerosis, Cognitive Disorders Trial in Isfahan (TENS)

    Unknown status
    • Multiple Sclerosis
    • Cognitive Disorders
    • TENS
    • Isfahan, Iran, Islamic Republic of
      Alzahra Hospital
    Aug 22, 2016

    Cognitive Disorders Trial in Lenexa (SUVN-D4010, Placebo)

    Completed
    • Cognitive Disorders
    • Lenexa, Kansas
      PRA Health Sciences
    Jun 3, 2016

    Delirium, Inflammation, Cognitive Disorders Trial in Recife (Ketamine, Saline)

    Unknown status
    • Delirium
    • +4 more
    • Recife, Pernambuco, Brazil
      Instituto de Medicina Integral Prof Fernando Figueira
    May 24, 2016

    Diabetes, Cancer, Multiple Sclerosis Trial in Tucson (Exergame, Home based balance training)

    Unknown status
    • Diabetes
    • +7 more
    • Exergame
    • Home based balance training
    • Tucson, Arizona
      University of Arizona
    May 16, 2016